Jubilant Ingrevia wins Rs 270 crore specialty chemicals contract

Jubilant Ingrevia has received a CDMO contract worth Rs 270 crore from an international customer to supply two GMP intermediates for a patented drug over three years. Commercial supplies will start in the current financial year.

“The pursuit of growth is one of the key features of our strategy. Today's announcement is in line with our strategy & commitment to grow our CDMO business of value-added GMP & Non GMP intermediates.”economictimes.indiatimes.com

• 1 source
• economictimes.indiatimes.comJubilant Ingrevia share price: Jubilant Ingrevia zooms 6% on bagging Rs 270 crore specialty chemicals contract - The Economic TimesBhaskar DuttaApr 18, 2022

Summarized from public sources; check the original articles before acting on it.